Thiazolidinediones but Not Metformin Directly Inhibit the Steroidogenic Enzymes P450c17 and 3β-Hydroxysteroid Dehydrogenase
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Androgen biosynthesis requires 3beta-hydroxysteroid dehydrogenase type II (3betaHSDII) and the 17alpha-hydroxylase and 17,20-lyase activities of cytochrome P450c17. Thiazolidinedione and biguanide drugs, which are used to increase insulin sensitivity in type 2 diabetes, lower serum androgen concentrations in women with polycystic ovary syndrome. However, it is unclear whether this is secondary to increased insulin sensitivity or to direct effects on steroidogenesis. To investigate potential actions of these drugs on P450c17 and 3betaHSDII, we used "humanized yeast" that express these steroidogenic enzymes in microsomal environments. The biguanide metformin had no effect on either enzyme, whereas the thiazolidinedione troglitazone inhibited 3betaHSDII (K(I) = 25.4 +/- 5.1 microm) and both activities of P450c17 (K(I) for 17alpha-hydroxylase, 8.4 +/- 0.6 microm; K(I) for 17,20-lyase, 5.3 +/- 0.7 microm). The action of troglitazone on P450c17 was competitive, but it was mainly a noncompetitive inhibitor of 3betaHSDII. The thiazolidinediones rosiglitazone and pioglitazone exerted direct but weaker inhibitory effects on both P450c17 and 3betaHSDII. These differential effects of the thiazolidinediones do not correlate with their effects on insulin sensitivity, suggesting that distinct regions of the thiazolidinedione molecule mediate these two actions. Thus, thiazolidinediones inhibit two key enzymes in human androgen synthesis contributing to their androgen-lowering effects, whereas metformin affects androgen synthesis indirectly, probably by lowering circulating insulin concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG. 2 Effect of metformin and troglitazone on the differential activities of human P450c17. A , 17 a -hydroxylase activity. Microsomes prepared from yeast coexpressing human P450c17 and human P450 oxidoreductase were incubated with 1 m M [ 14 C]progesterone ( Prog ) and 0-100 m M metformin ( MET ) and troglitazone ( TRO ). 17 a -Hydroxylase activity was assessed as the conversion rate of [ 14 C]progesterone to 17OHP. B , 17,20-lyase activity. Microsomes coexpressing P450c17 and OR were incubated with 1 m M 17-Preg and 0-100 m M metformin and troglitazone. 17,20-Lyase activity was assessed as the conversion rate of [ 3 H]17 a -hydroxypregnenolone to DHEA. Each data point represents the mean 6 S.D. of triplicate determinations.](https://figures.cochat.ai/paper-figures/4221417a95fd41fd829b22d85a3904cd/thiazolidinediones-but-not-metformin-directly-inhibit-the-steroidogenic-enzymes-figure-2.png)
![FIG. 3 Kinetic analysis of the mode of inhibition of P450c17 activities by troglitazone ( TRO ). Lineweaver-Burk plots of 17 a -hydroxylase activity ( A ) and 17,20-lyase activity ( B ) and Dixon plot of 17 a -hydroxylase activity ( C ) in the absence and presence of troglitazone (0-20 m M) and with 0.5, 1, 2, and 4 m M [ 14 C]progesterone ( Prog ) and 17-Preg for the assessment of 17 a -hydroxylase and 17,20-lyase activity, respectively. Incubations were carried out with yeast microsomes (40 m g of total protein) coexpressing human P450c17 and human P450 oxidoreductase. Each data point represents the mean 6 S.D. of triplicate determinations.](https://figures.cochat.ai/paper-figures/0a2f41b8bc8041eeafe30abc2029b10d/thiazolidinediones-but-not-metformin-directly-inhibit-the-steroidogenic-enzymes-figure-3.png)
![FIG. 4 Inhibition of 17 a -hydroxylase activity by troglitazone ( TRO ) in whole cells ( solid line ) and in yeast microsomes ( dotted line ). COS-1 cells transiently expressing human P450c17 and yeast microsomes expressing both P450c17 and P450 oxidoreductase were incubated with [ 14 C]progesterone ( Prog ), and 17 a -hydroxylase activity was determined as the conversion rate of [ 14 C]progesterone to 17OHP. Each data point represents the mean 6 S.D. of triplicate determinations.](https://figures.cochat.ai/paper-figures/00ca13bafc4b44c9ba9879e6bf50d444/thiazolidinediones-but-not-metformin-directly-inhibit-the-steroidogenic-enzymes-figure-4.png)


![FIG. 6 Kinetic analysis of the mode of inhibition of 3 b HSDII activity by troglitazone ( TRO ). Lineweaver-Burk plot ( A ) and Dixon plot ( B ) of 3 b HSDII activity. Incubations were carried out with yeast microsomes (40 m g total protein) expressing human 3 b HSDII in the absence and presence of troglitazone (0-60 m M) with 1, 5, 10, and 20 m M [ 14 C]pregnenolone ( Preg ). Each data point represents the mean 6 S.D. of triplicate determinations.](https://figures.cochat.ai/paper-figures/3eb67229e31543189611c7633bbcc3df/thiazolidinediones-but-not-metformin-directly-inhibit-the-steroidogenic-enzymes-figure-6.png)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Improved method for high efficiency transformation of intact yeast cells
Gietz, D., Jean, A. S., Woods, R. A., & Schiestl, R. H. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.6.1425 · Cited by 3,261
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730
Aromatase Cytochrome P450, The Enzyme Responsible for Estrogen Biosynthesis*
SIMPSON, E. R., MAHENDROO, M. S., MEANS, G. D., KILGORE, M. W., HINSHELWOOD, M. M., GRAHAM-LORENCE, S., AMARNEH, B., ITO, Y., FISHER, C. R., MICHAEL, M. D., et al. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-342 · Cited by 1,537
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Molecular biology of steroid hormone synthesis
MILLER, W. L. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-3-295 · Cited by 1,397
Self-citationEfficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
DeFronzo, R. A., & Goodman, A. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330902 · Cited by 1,368
Research works printed but not linked: 12
- 5. Penning, T. M. (1997) Endocr. Rev. 18, 281-305
- 6. Simpson, E. R., Mahendroo, M. S., Means, G. D., Kilgore, M. W., Hinshelwood, M. M., Graham-Lorence, S., Amarneh, B., Ito, Y., Fisher, C. R., Michael, M. D., Mendelson, C. R., and Bulun, S. C. (1994) Endocr. Rev. 15, 342-355
- 7. Lin, D., Black, S. M., Nagahama, Y., and Miller, W. L. (1993) Endocrinology 132, 2498 -2506 · doi:10.1210/endo.132.6.8504753 · Paper page
- 10. Dunaif, A. (1997) Endocr. Rev. 18, 774 -800
- 13. Dunaif, A., Scott, D., Finegood, D., Quintana, B., and Whitcomb, R. (1996) J. Clin. Endocrinol. Metab. 81, 3299 -3306
- 14. Ehrmann, D. A., Schneider, D. J., Sobel, B. E., Cavaghan, M. K., Imperial, J., Rosenfield, R. L., and Polonsky, K. S. (1997) J. Clin. Endocrinol. Metab. 82, 2108 -2116
- 21. Lee, T. C., Miller, W. L., and Auchus, R. J. (1999) J. Clin. Endocrinol. Metab. 84, 2104 -2110
- 26. Dixon, M., and Webb, E. C. (1979) Enzymes 3rd Ed., Academic Press, New York
- 31. Nestler, J. E., and Jakubowicz, D. J. (1997) J. Clin. Endocrinol. Metab. 82, 4075-4079
- 35. Crave, J. C., Fimbel, S., Lejeune, H., Cugnardey, N., Dechaud, H., and Pugeat, M. (1995) J. Clin. Endocrinol. Metab. 80, 2057-2062
- 37. Maeshiba, Y., Kiyota, Y., Yamashita, K., Yoshimura, Y., Motohashi, M., and Tanayama, S. (1997) Arzneim. Forsch. 47, 29 -35
- 38. Cox, P. J., Ryan, D. A., Hollis, F. J., Harris, A. M., Miller, A. K., Vousden, M., and Cowley, H. (2000) Drug Metab. Dispos. 28, 772-780
Cited by
Items 101–157 of 157
Silva, A. R., Gonçalves-de-Albuquerque, C. F., Pérez, A. R., & Carvalho, V. F. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.008 · Cited by 19
Elkind-Hirsch, K. E. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605030-00005 · Cited by 20
Ohn, J., Son, H., Yu, D., Kim, M. S., Kwon, S., Park, W.-S., Kim, J., & Kwon, O. (2022) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2022.02.011 · Cited by 18
Key signalling pathways underlying the aetiology of polycystic ovary syndrome
Walters, K. A., Moreno-Asso, A., Stepto, N. K., Pankhurst, M. W., Paris, V. R., & Rodgers, R. J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0059 · Cited by 19
Couto, J. A., Saraiva, K. L. A., Barros, C. D., Udrisar, D. P., Peixoto, C. A., Vieira, J. S. B. C., de Lima, M. D. C. A., Galdino, S. L., Pitta, I. D. R., & Wanderley, M. I. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-13 · Cited by 16
“It has been demonstrated that TDZs have a considerable impact on the production and metabolism of gonad hormones [6,8, 14 ,17-20].”
BackgroundInfluentialGlukokortikoidinduzierte Insulinresistenz und Diabetes mellitus
Meyer, G., & Badenhoop, K. W. J. (2003) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-003-1255-z · Cited by 19
Pioglitazone administration alters ovarian gene expression in aging obese lethal yellow mice
Brannian, J. D., Eyster, K. M., Weber, M., & Diggins, M. R. (2008) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-6-10 · Cited by 15
“For example, TZD (troglitazone), but not metformin, reduced androgen levels by directly suppressing 3β-hydroxysteroid dehydrogenase and cytochrome P450 17α-hydroxylase, two key enzymes in the androgenic pathway [10].”
Mansour, M. M., Coleman, E. S., Dennis, J. C., Akingbemi, B. T., Schwartz, D. D., Braden, T. D., Judd, R. L., Plaisance, E. P., Stewart, L., & Morrison, E. E. (2009) · PPAR Research · doi:10.1155/2009/101857 · Cited by 17
“finding is firmly in line with studies that showed strong TZDPPARγ activation [48, 49] but weaker in vitro steroidogenic inhibitory effects of rosiglitazone [13].”
BackgroundResultInfluentialThe Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 37
Self-citationMatsushita, M., Tamura, K., Osada, S., & Kogo, H. (2005) · Endocrine · doi:10.1385/endo:27:3:301 · Cited by 12
Potential Utility of Insulin Sensitizers in the Treatment of Patients with Polycystic Ovary Syndrome
Bayram, F., Ünlühızarcı, K., & Keleştimur, F. (2002) · Treatments in Endocrinology · doi:10.2165/00024677-200201010-00005 · Cited by 13
Torres, R. C., Batista, M. M., Pons, A. H., Silva, A. R., Cordeiro, R. S. B., Martins, M. A., Silva, P. M. R. E., & Carvalho, V. F. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.06.010 · Cited by 13
The Hypothalamic-Pituitary Axis in PCOS
Okigbo, C. C., Gill, S., & Hall, J. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_5 · Cited by 17
Insulin resistance: what is its role in the polycystic ovary syndrome?
Moghetti, P. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200212000-00002 · Cited by 14
Sparić, R., Andjić, M., Rakić, A., Bjekić-Macut, J., Livadas, S., Kontić‐Vučinić, O., Mastorakos, G. P., & Μacut, D. (2023) · HORMONES · doi:10.1007/s42000-023-00494-y · Cited by 12
“Pioglitazone also inhibits the expression of 3b-hydroxysteroid dehydrogenase type II or cytochrome P450c17 enzymes, thereby decreasing androgen production [73].”
Adrenal and Polycystic Ovary Syndrome
Çelik, Ö., & Yıldız, B. O. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108989831.008 · Cited by 9
Nepelska, M., Odum, J., & Munn, S. (2017) · Applied In Vitro Toxicology · doi:10.1089/aivt.2017.0004 · Cited by 10
Gurusinghe, D., Gill, S., Almario, R. U., Lee, J., Horn, W. F., Keim, N. L., Kim, K., & Karakas, S. E. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.017 · Cited by 8
Ahmad, J., Shukla, N., Khan, A. R., Ahmed, F., & Siddiqui, M. A. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2007.12.003 · Cited by 10
The Role of the Ovary in the Genesis of Hyperandrogenism
Magoffin, D. A. (2004) · Elsevier eBooks · doi:10.1016/b978-012444562-8/50031-8 · Cited by 8
(1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100720 · Cited by 7
Effects of insulin-lowering drugs in PCOS: endocrine, metabolic and inflammatory aspects
Rautio, K. (2006) · Cited by 7
Development of relevant assay system to identify steroidogenic enzyme inhibitors
Nishizato, Y., Imai, S., Yabuki, M., Kido, H., & Komuro, S. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.07.037 · Cited by 5
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00022-6 · Cited by 4
Demissie, Y. N., Fiad, T. M., Klemm, K., Twfeeg, A., Alamoudi, A., Meer, L., & Elhadd, T. A. (2006) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2006.296 · Cited by 5
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00096-4 · Cited by 6
Self-citationShkumatov, V. M., Usova, E. V., Frolova, N. S., Barth, G., & Mauersberger, S. (2007) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750807010131 · Cited by 4
Effect of Weight Loss on Symptoms of Polycystic Ovarian Syndrome among Women of Reproductive Age
Dileep, A., Samy, M. A. F., Hussain, N., & AlAbdin, S. Z. (2021) · Dubai Medical Journal · doi:10.1159/000514025 · Cited by 6
Bopst, M., & Atzpodien, E.-A. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.03.003 · Cited by 4
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00020-6 · Cited by 6
Nishizato, Y., Imai, S., Yabunaka, A., Okahashi, N., Kunimatsu, T., & Yabuki, M. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.12.005 · Cited by 3
The link between polycystic ovary syndrome and Type 2 diabetes: what do we know today?
Sathyapalan, T., & Atkin, S. L. (2011) · Diabetes Management · doi:10.2217/dmt.11.59 · Cited by 4
Toda, K., Hayashi, Y., Ono, M., & Saibara, T. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.027 · Cited by 3
“Thus, expanding our knowledge about the molecular mechanisms underlying anovulatory phenotype of ArKO mice and the beneficial effects of insulin might contribute to the development of novel therapeutic options for the treatment of patients with PCOS.”
BackgroundTreatment of Infertility in Polycystic Ovary Syndrome: Ovulation Induction
Wachs, D. S., & Chang, R. J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_3 · Cited by 3
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00097-4 · Cited by 3
Self-citationRecommendations for the Early Recognition and Prevention of Polycystic Ovary Syndrome
Chang, R. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_10 · Cited by 2
“In contrast, metformin was not associated with changes in 17-hydroxylase or 3HSD in studies of yeast cells ( 39 ).”
BackgroundOxytocin modulates steroidogenesis-associated genes and estradiol levels in the placenta
An, S., Kim, M. J., Jeong, J. S., Kim, S. Y., Kim, D. S., An, B., & Kim, S. C. (2023) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2023.2170296 · Cited by 2
“Androgens, which contain testosterone (T), are synthesized from DHEA and P4 using 17b-dehydrogenase 3 (HSD17B3) and HSD3B1 (Arlt et al. 2001).”
MethodThe Hypothalamic–Pituitary Axis in PCOS
Gill, S., & Hall, J. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_6 · Cited by 5
Insulin Resistance in the Pathophysiology of Polycystic Ovary Syndrome
Chada, S. R., & Sahay, R. K. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810931125010014 · Cited by 1
Meng, C., Luo, P., Ren, W., Xie, X., Zeng, Y., Wang, J., Yao, X., & Meng, J. (2026) · BMC Genomics · doi:10.1186/s12864-026-13131-w · Cited by 1
Fuel Sensor PPARγ: a Potential Gateway for Fertility Regulation in Buffalo
Singh, D., Sharma, I., & Onteru, S. K. (2013) · Buffalo Bulletin · Cited by 1
TOPAL, M., Altay, D. U., Şahin, E., & Alver, A. (2022) · Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi · doi:10.37989/gumussagbil.1001449 · Cited by 1
Therapeutic Effects of Metformin and Rosiglitazone in Korean Women with Polycystic Ovary Syndrome
Oh, J. Y., Byun, E. K., Park, H. R., Choi, Y. J., Kim, H. J., Lee, H. J., Hong, Y. S., Sung, Y., & Chung, H. W. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.5.467 · Cited by 1
“그러나 Arlt등은 thiazolidinedione이 안드로겐 생합성에 관련된 두가지의 중 요한 효소 (3β-hydroxysteroid dehydrogenase type II, 17 α -hydroxylase 및 17,20-lyase activities of cytochrome P450 c17)을 억제하지만 metformin은 이러한 효과는 없으며 혈 중 인슐린 농도를 감소시킴으로써 간접적으로 안드로겐 생 합성을 억제할 것이라는 상반되는 결과를 보고하였다[31].”
Hypothalamic-Pituitary-Adrenal Dysfunction in the Polycystic Ovary Syndrome
Yıldız, B. O., Carmina, E., & Azziz, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_19 · Cited by 1
“In these women, circulating DHEAS levels decreased 18–26% with troglitazone 600 mg/day, but not placebo, regardless of basal DHEAS level (Fig. 2). Nevertheless, troglitazone alters androgen biosynthesis directly ( 68 ) and ovarian androgen secretion indirectly (69), which may have contributed to the observed results.”
ResultYıldız, Y., Özakşit, G., Eyı, E. G. Y., Özgü, E., Ünlü, B. S., & Energin, H. (2012) · DergiPark (Istanbul University)
TRATAMIENTO DEL SÍNDROME DE OVARIO POLIQUÍSTICO. SENSIBILIZADORES DE INSULINA
Velázquez-Maldonado, E., & Nottola, N. (2007) · Revista Venezolana de Endocrinología y Metabolismo
Baba, T., Endo, T., Ikeda, Shimizu, Morishita, Kuno, Honnma, H., Kiya, Ishioka, & Saito (2012) · International Journal of Women s Health · doi:10.2147/ijwh.s36667
Vasoreactivity, Inflammation and vascular effects of Thiazolidinediones in Insulin resistance
Martens, F. M. A. C. (2006) · Utrecht University Repository (Utrecht University)
Serine Phosphorylation, Insulin Resistance, and the Regulation of Androgen Synthesis
Bremer, A. A., & Miller, W. L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_8
“Measurements of serum steroids suggested that metforrnin inhibits P450c17 (72-74), but direct studies of metformin on human steroidogenic enzymes showed no effects on P450cl7 or 3~-HSD2 ( 75 ) . Thus, the action of metformin to decrease circulating androgens is probably secondary to its reduction of insulin levels.”
BackgroundSelf-citationPPAR-γ: A Master Metabolic Nuclear Receptor
Onteru, S. K., & Singh, D. (2013) · Journal of Endocrinology & Reproduction · doi:10.18519/jer/2013/v17/75785
Solano, M. E. (2010) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Adrenal androgens in the polycystic ovary syndrome
Azziz, R. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200212000-00005 · Cited by 1
Meyer, G., & Badenhoop, K. W. J. (2003) · Medizinische Klinik - Intensivmedizin und Notfallmedizin
Adrenocortical dysfunction in polycystic ovary syndrome
Yıldız, B. O., & Azziz, R. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545191.017
Sandler, C. N., & SHANK, K. R. (2024) · Springer eBooks · doi:10.1007/978-3-031-54281-7_40
Antoniou-Tsigkos, A., Καρράς, Γ., Papagianni, M., CHRISTOPOULOS, P. F., Vlahos, N. F., & Mastorakos, G. M. (2025) · Endocrine · doi:10.1007/s12020-025-04527-x
“Authors have suggested that flutamide in low-doses is safe, but there are not enough well-powered studies to confirm microsomal environment, was employed [110].”
Rôle des adipocytokines dans l'obésité, l'insulino-résistance et leurs conséquences sur la fertilité
Bongrani, A. (2022) · theses.fr (ABES) · doi:10.70675/1b281dcdz1f16z4985z95f8z0706a492c996
Metadata
- Authors
- Arlt, W., Auchus, R. J., & Miller, W. L.
- Affiliations
- University of California, San Francisco (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Miller, Walter L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 276
- Issue
- 20
- Pages
- 16767-16771
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2050353370
- Semantic Scholar
- 882bbddf93d24e3507b22bb163aad3ac5fa2f1ce
- Cited by
- 157
- References
- 42
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 7 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 5 · 2014: 3 · 2013: 7 · 2012: 7
- FWCI
- 12.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7088 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft
- National Institutes of Health (5k08dk002387-06)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08 DK 02387, R01DK037922, R01DK37922)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54-HD34449, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- thiazolidinediones, metformin, P450c17, steroidogenesis, androgen production, troglitazone, rosiglitazone, pioglitazone, polycystic ovary syndrome, enzyme inhibition, insulin sensitivity, type 2 diabetes
- MeSH terms
- Pioglitazone, Troglitazone, Biguanides, Chromans, Cloning, Molecular, Humans, Kinetics, Metformin, Recombinant Proteins, Saccharomyces cerevisiae, Steroid Hydroxylases, Steroid 17-alpha-Hydroxylase, Thiazoles, 3-Hydroxysteroid Dehydrogenases, Thiazolidinediones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.